Emerging Risk of Campylobacter spp. Infection Associated With Anti-BCMA and Anti-GPRC5D Bispecific Antibodies - Quiz - MDSpire

Emerging Risk of Campylobacter spp. Infection Associated With Anti-BCMA and Anti-GPRC5D Bispecific Antibodies

  • By

  • Idoia Bilbao

  • María Ansón

  • Sara Villar

  • Iñigo Pineda

  • Laura Gárriz

  • Manuel Pina-Sánchez

  • Luis-Esteban Tamariz-Amador

  • Paula Rodríguez-Otero

  • José Ramón Yuste

  • José L del Pozo

  • November 4, 2025

  • 0 min

Share

Original Source(s)

Emerging Risk of Campylobacter spp. Infection Associated With Anti-BCMA and Anti-GPRC5D Bispecific Antibodies

  • by Idoia Bilbao, María Ansón, Sara Villar, Iñigo Pineda, Laura Gárriz, Manuel Pina-Sánchez, Luis-Esteban Tamariz-Amador, Paula Rodríguez-Otero, José Ramón Yuste, José L del Pozo

  • November 4, 2025

Related Content

Sustained remission following finite duration bispecific antibody therapy in patients with relapsed/refractory myeloma

Hematopoietic cell transplantation and cell therapy activity landscape survey in the Kingdom of Saudi Arabia; a report from the Saudi Society of Blood and Marrow Transplantation (SSBMT)

Updates and Advancements in Cellular Therapy at Roswell Park

Originally Broadcast: Thursday, November 9, 2023 6:00 - 7:30 PM EST - This program is intended for Hematologists, Oncologists, Pharmacists, Pathologists, and other healthcare professionals that care for cancer patients.

  • October 18, 2023

  • 2 min